These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17302372)

  • 1. Indomethacin has a potent antiviral activity against SARS coronavirus.
    Amici C; Di Caro A; Ciucci A; Chiappa L; Castilletti C; Martella V; Decaro N; Buonavoglia C; Capobianchi MR; Santoro MG
    Antivir Ther; 2006; 11(8):1021-30. PubMed ID: 17302372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
    Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
    Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin-based PROTACs as pan-coronavirus antiviral agents.
    Desantis J; Mercorelli B; Celegato M; Croci F; Bazzacco A; Baroni M; Siragusa L; Cruciani G; Loregian A; Goracci L
    Eur J Med Chem; 2021 Dec; 226():113814. PubMed ID: 34534839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: Impact on virus-induced COX-2 expression.
    Tramontozzi C; Riccio A; Pauciullo S; La Frazia S; Rossi A; Santoro MG
    J Virus Erad; 2024 Sep; 10(3):100387. PubMed ID: 39399815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
    Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Chan PK; Sidwell RW
    Antivir Chem Chemother; 2006; 17(5):275-84. PubMed ID: 17176632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.
    Li C; Chu H; Liu X; Chiu MC; Zhao X; Wang D; Wei Y; Hou Y; Shuai H; Cai J; Chan JF; Zhou J; Yuen KY
    Emerg Microbes Infect; 2020 Dec; 9(1):2663-2672. PubMed ID: 33179566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus.
    Yang CW; Lee YZ; Kang IJ; Barnard DL; Jan JT; Lin D; Huang CW; Yeh TK; Chao YS; Lee SJ
    Antiviral Res; 2010 Nov; 88(2):160-8. PubMed ID: 20727913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.
    Gomeni R; Xu T; Gao X; Bressolle-Gomeni F
    J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):189-198. PubMed ID: 32435882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
    Chu CK; Gadthula S; Chen X; Choo H; Olgen S; Barnard DL; Sidwell RW
    Antivir Chem Chemother; 2006; 17(5):285-9. PubMed ID: 17176633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha.
    Ströher U; DiCaro A; Li Y; Strong JE; Aoki F; Plummer F; Jones SM; Feldmann H
    J Infect Dis; 2004 Apr; 189(7):1164-7. PubMed ID: 15031783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
    Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of SARS virus replication by human interferons.
    Dahl H; Linde A; Strannegård O
    Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid.
    He R; Adonov A; Traykova-Adonova M; Cao J; Cutts T; Grudesky E; Deschambaul Y; Berry J; Drebot M; Li X
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1199-203. PubMed ID: 15249217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
    de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.
    Morgenstern B; Michaelis M; Baer PC; Doerr HW; Cinatl J
    Biochem Biophys Res Commun; 2005 Jan; 326(4):905-8. PubMed ID: 15607755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis.
    Son J; Huang S; Zeng Q; Bricker TL; Case JB; Zhou J; Zang R; Liu Z; Chang X; Darling TL; Xu J; Harastani HH; Chen L; Gomez Castro MF; Zhao Y; Kohio HP; Hou G; Fan B; Niu B; Guo R; Rothlauf PW; Bailey AL; Wang X; Shi PY; Martinez ED; Brody SL; Whelan SPJ; Diamond MS; Boon ACM; Li B; Ding S
    mBio; 2022 Feb; 13(1):e0337721. PubMed ID: 35038906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.